Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Articles by Staff Report  -  Page 297
Latest

Companies Pitch at GEM Demo Day

By   /  Wednesday, August 10th, 2016  /  Latest news  /  Comments Off on Companies Pitch at GEM Demo Day

Six companies presented to investors, colleagues and friends Aug. 9 as the Goleta Entrepreneurial Magnet held a demo day for for regional companies. The Goleta Entrepreneurial Magnet held the event for six teams that finished its seven week G2 Summer Accelerator at the Bacara Resort & Spa Aug.n9 Among the teams that presented was Vibe; Read More →

Read More →
Latest

Stellar Biotechnologies revenues up but losses grow

By   /  Tuesday, August 9th, 2016  /  Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Stellar Biotechnologies revenues up but losses grow

Stellar Biotechnologies’ revenues increased slightly during the third quarter of 2016 but losses widened as the company signed a new partnership with a French company and held an offering for institutional investors, the company said in a quarterly earnings report Aug. 8. Stellar revenues increased slightly from $157,748 during the third quarter of 2015 to Read More →

Read More →
Latest

AppFolio second quarter revenues up, net loss down

By   /  Monday, August 8th, 2016  /  Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on AppFolio second quarter revenues up, net loss down

AppFolio raised its financial outlook for the year as revenues increased sharply and losses narrowed in the second quarter, the company said Aug. 8. AppFolio, a Goleta-based developer of property management software for small- to medium-sized property managers, raised full-year financial-guidance estimates to a range between $103 million and $105 million Aug. 8. Previous estimates Read More →

Read More →
Latest

Inphi’s second quarter revenues soar

By   /  Monday, August 8th, 2016  /  Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Inphi’s second quarter revenues soar

Inphi saw revenues rise during the second quarter as it sold off its memory products business. On June 30, Inphi announced it would sell its memory products business to Sunnyvale-based Rambus. Inphi said revenues rose from $49.4 million in 2015 to $60.5 million during the second quarter of 2016 when revenues from the memory business Read More →

Read More →
Latest

OCB Bancorp’s second quarter net income up over last year

By   /  Monday, August 8th, 2016  /  Banking & Finance, Banking Industry, Earnings, Latest news, Tri-County Public Companies  /  Comments Off on OCB Bancorp’s second quarter net income up over last year

In its second quarter earnings report, OCB Bancorp — parent company of Ojai Community Bank, Santa Barbara Community Bank, Ventura Community Bank and Santa Paula Community Bank — reported net income year-to-date of $516,000, or 25 cents per share, up from $372,000 last year. “Loans also continue to grow, increasing approximately $49 million since June Read More →

Read More →
Latest

Santa Barbara’s Aurrion acquired for $165 million

By   /  Monday, August 8th, 2016  /  Latest news, Technology  /  Comments Off on Santa Barbara’s Aurrion acquired for $165 million

Sunnyvale-based Juniper Networks announced Aug. 4 in a quarterly filing with the Securities and Exchange Commission it acquired Santa Barbara-based silicon photonic chip maker Aurrion for $165 million. Aurrion makes components that transmit information quickly using cheap, easily mass-produced silicon wafers. UC Santa Barbara professor John Bowers founded Aurrion in 2008 and the company quickly Read More →

Read More →
Latest

Abbvie sues Amgen to block sales of Humira biosimilar

By   /  Friday, August 5th, 2016  /  Central Coast Health Watch, Latest news, Law, Technology  /  Comments Off on Abbvie sues Amgen to block sales of Humira biosimilar

Thousand Oaks-based biotech giant Amgen faces a lawsuit seeking to block it from selling a biosimilar of AbbVie’s popular Humira. The rheumatoid arthritis medicine is Abbvie’s best seller. Sales were up 17 percent in the second quarter to $4.15 billion and accounted for 61 percent of AbbVie’s 2015 revenue. Abbvie claims Amgen’s proposed copy would Read More →

Read More →